MedTrace Logo

Intravenous Versus Intraperitoneal Instillation of Ondansetron for Decreasing Incidence of Nausea and Vomiting After Laparoscopic Gynecological Surgeries.

NCT05317611 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2025-02-04

No results posted yet for this study

Summary

Study the effect of intraperitoneal instillation vs intravenous ondansetron on PONV added to intraperitoneal bupivacaine for enhanced recovery and to decrease incidence of PONV after laparoscopic surgeries.

Conditions

  • Prevention

Interventions

DRUG

Intraperitoneal instillation of ondansetron and bupivacaine

The aim is to detect the effect of intraperitoneal instillation of ondansetron for prevention of postoperative nausea and vomiting

DRUG

Intravenous ondansetron and intraperitoneal instillation of bupivacaine

The aim is to detect effect of intravenous ondansetron for prevention of postoperative nausea and vomiting

DRUG

Intraperitoneal instillation of bupivacaine

The aim is to detect effect of intraperitoneal instillation of bupivacaine

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2025-01-15
Completion
2025-01-26

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05317611 on ClinicalTrials.gov